Humoral response to BNT162b2-COVID-19 or CoronaVac vaccine against COVID-19 in people with multiple sclerosis patients treated with high efficacy therapies

被引：0
|
作者：
Galleguillos, L. [1 ]
Alonso, R. [2 ]
Kagi, M. [3 ]
Hernandez, M. [1 ]
Diaz, V. [1 ]
Pallauta, K. [4 ]
Jerez, M. E. [4 ]
机构：
[1] Clin Alemana, Neurol & Psiquiatria, Santiago, Chile
[2] Hosp Ramos Mejia, Neurol, Buenos Aires, DF, Argentina
[3] Clin Davila, Neurol & Neurocirugia, Santiago, Chile
[4] Univ Los Andes, Neurol, Santiago, Chile
来源：
MULTIPLE SCLEROSIS JOURNAL | 2021年 / 27卷 / 2_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P974
引用
收藏
页码：792 / 792
页数：1
相关论文
共 50 条
  • [21] Correspondence to: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
    Piquet, Amanda L.
    Corboy, John R.
    Vollmer, Timothy L.
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2021, 14
  • [22] Effect of Heterologous Vaccination Strategy on Humoral Response against COVID-19 with CoronaVac plus BNT162b2: A Prospective Cohort Study
    Demirhindi, Hakan
    Mete, Burak
    Tanir, Ferdi
    Kara, Ertan
    Kibar, Filiz
    Cetiner, Salih
    Candevir, Aslihan
    Akti, Sukriye Ece
    VACCINES, 2022, 10 (05)
  • [23] CoronaVac, BNT162b2 and heterologous COVID-19 vaccine and ventricular assist device: Correspondence
    Kleebayoon, Amnuay
    Wiwanitkit, Viroj
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2023, 46 (05): : 255 - 255
  • [24] Waning COVID-19 Vaccine Effectiveness for BNT162b2 and CoronaVac in Malaysia: An Observational Study
    Suah, Jing Lian
    Husin, Masliyana
    Tok, Peter Seah Keng
    Tng, Boon Hwa
    Thevananthan, Thevesh
    Low, Ee Vien
    Appannan, Maheshwara Rao
    Zin, Faizah Muhamad
    Zin, Shahanizan Mohd
    Yahaya, Hazlina
    Peariasamy, Kalaiarasu M.
    Sivasampu, Sheamini
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 119 : 69 - 76
  • [25] Humoral response after 3 doses of the BNT162b2 mRNA COVID-19 vaccine in patients on hemodialysis
    Ducloux, Didier
    Colladant, Mathilde
    Chabannes, Melchior
    Yannaraki, Maria
    Courivaud, Cecile
    KIDNEY INTERNATIONAL, 2021, 100 (03) : 702 - 704
  • [26] Humoral response to BNT162b2 mRNA COVID-19 vaccine in peritoneal and hemodialysis patients: A comparative study
    Duarte, Rui
    Roldao, Marisa
    Figueiredo, Catia
    Luz, Ivan
    Ferrer, Francisco
    Goncalves, Hernani
    Sofia, Flora
    Lopes, Karina
    THERAPEUTIC APHERESIS AND DIALYSIS, 2022, 26 (04) : 790 - 796
  • [27] The Humoral Response of Patients With Cancer to Breakthrough COVID-19 Infection or the Fourth BNT162b2 Vaccine Dose
    Cohen, Idan
    Campisi-Pfinto, Salvatore
    Rozenberg, Orit
    Colodner, Raul
    Bar-Sela, Gil
    ONCOLOGIST, 2023, : e225 - e227
  • [28] BNT162b2 Covid-19 Vaccine in Adolescents
    Lin, Chen-Hsing
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (14): : 1342 - 1343
  • [29] Humoral vaccine response and COVID-19 hospitalizations in vaccinated multiple sclerosis patients treated with rituximab
    Torgauten, H.
    Onyangp, T.
    Hallin, E.
    Serkland, T.
    Skrede, S.
    Cox, R.
    Langeland, N.
    Myhr, K.
    Torkildsen, O.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 736 - 736
  • [30] Cellular and humoral response to the fourth BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL
    Benjamini, Ohad
    Gershon, Rotem
    Bar-Haim, Erez
    Lustig, Yaniv
    Cohen, Hila
    Doolman, Ram
    Kedmi, Meirav
    Ribakovsky, Elena
    Kneller, Abraham
    Hod, Tammy
    Erez, Noam
    Levy, Itzhak
    Rahav, Galia
    Avigdor, Abraham
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 110 (01) : 99 - 108
12345